P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA.
M. Sims,
G. Ward,
Z. Zhang,
S. Jueliger,
M. Davis,
A. Boxall,
J. Taylor,
A. Biondo,
J. Lyons,
T. Smyth
Affiliations
M. Sims
1 Translational Sciences
G. Ward
1 Translational Sciences
Z. Zhang
1 Translational Sciences
S. Jueliger
1 Translational Sciences
M. Davis
2 Bioinformatics, Astex Pharmaceuticals Limited, Cambridge, United Kingdom
A. Boxall
2 Bioinformatics, Astex Pharmaceuticals Limited, Cambridge, United Kingdom
J. Taylor
3 Clinical Development, Astex Pharmaceuticals Inc, Pleasanton, United States of America
A. Biondo
1 Translational Sciences
J. Lyons
1 Translational Sciences
T. Smyth
4 DMPK, Astex Pharmaceuticals Limited, Cambridge, United Kingdom
